MedPath

成都倍特得诺药业有限公司

Ownership
-
Established
2018-01-30
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

66

NMPA:66

Drug Approvals

Potassium Chloride Oral Solution

Product Name
氯化钾口服溶液
Approval Number
国药准字H20253963
Approval Date
Apr 22, 2025
NMPA

Potassium Chloride Oral Solution

Product Name
氯化钾口服溶液
Approval Number
国药准字H20253962
Approval Date
Apr 22, 2025
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20258037
Approval Date
Mar 21, 2025
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20258036
Approval Date
Mar 21, 2025
NMPA

Baclofen Oral Solution

Product Name
巴氯芬口服溶液
Approval Number
国药准字H20253329
Approval Date
Jan 24, 2025
NMPA

Procaterol Hydrochloride Oral Solution

Product Name
盐酸丙卡特罗口服溶液
Approval Number
国药准字H20244869
Approval Date
Sep 10, 2024
NMPA

Betamethasone Sodium Phosphate Injection

Product Name
倍他米松磷酸钠注射液
Approval Number
国药准字H20244470
Approval Date
Jul 22, 2024
NMPA

Nimodipine Oral Solution

Product Name
尼莫地平口服溶液
Approval Number
国药准字H20244290
Approval Date
Jun 28, 2024
NMPA

糖脉康颗粒

Approval Number
国药准字Z10970026
Approval Date
Jun 14, 2024
NMPA

宫瘤清胶囊

Approval Number
国药准字Z10980032
Approval Date
Jun 14, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.